GlassScriptPhysician profile
Roy Edward Lehman
NPI 1124314067
$6,672.04
in general payments reported to CMS, 2019-2025
28 companies · $1,395 in 2025
The $1,395 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $2,354 · 2021: $542 · 2022: $346 · 2023: $545 · 2024: $490 · 2025: $1,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,808 · Consulting Fee: $575 · Honoraria: $25.59 · Education: $20.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.94 |
| Consulting Fee | $575.00 |
| Honoraria | $25.59 |
| Education | $20.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $1,535.24 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $962.93 | 2022-2025 | Stellaris Elite, Envista Envy Iol, Envista Mx60 Iol |
| Glaukos Corporation | $656.86 | 2020-2025 | Idosetr, Idose, Istent Infinite |
| Alcon Vision LLC | $446.32 | 2019-2024 | Ngenuity, Luxor |
| Abbvie INC. | $398.01 | 2022-2025 | |
| Allergan, INC. | $371.33 | 2019-2022 | |
| Biotissue Holdings INC. | $349.26 | 2021-2025 | |
| Rxsight INC | $276.19 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $245.42 | 2019-2020 | |
| Ellexiscience | $221.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $218.75 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $146.80 | 2019-2022 | |
| Sight Sciences, INC. | $141.45 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Dompe US, INC. | $99.61 | 2019-2025 | Oxervate |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $98.45 | 2024-2025 | Eylea Hd, Eylea |
| Ocular Therapeutix, INC. | $97.62 | 2021 | |
| Lensar, INC. | $73.75 | 2020 | |
| Harrow Eye, LLC | $53.80 | 2024-2025 | Vevye |
| Nova Eye, INC. | $31.64 | 2025 | |
| Genentech USA, INC. | $26.05 | 2022 | |
| Biogen, INC. | $19.76 | 2022 | |
| Carl Zeiss Meditec, INC. | $19.74 | 2019 | |
| Shire North American Group INC | $17.61 | 2019 | |
| New World Medical,INC. | $17.31 | 2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Beaver-Visitec International, INC. | $15.36 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $15.20 | 2024 | |
| Aerie Pharmaceuticals, INC. | $14.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Lehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.